This week it has been reported that the pharmaceutical giant AstraZeneca is ‘exploring options’ for its COVID-19 vaccine business, including a sale. This is not entirely surprising. The company has not traditionally focused on vaccines and its vital contribution to the fight against the coronavirus may never make a profit. However, AstraZeneca’s experience still reflects … Continue reading The EU’s vaccine failures will leave a toxic legacy →